• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

5-Aminopentanoic Acid Benzyl Ester Tosylate: A Versatile Compound in Medicinal Chemistry

5-Aminopentanoic Acid Benzyl Ester Tosylate is a promising compound with significant potential in the field of medicinal chemistry. This molecule, characterized by its CAS number 63649-14-9, represents a unique structural feature that combines the functionalities of 5-aminopentanoic acid, benzyl ester, and tosylate groups. The integration of these functional groups not only enhances the chemical stability of the compound but also provides opportunities for targeted drug delivery and improved bioavailability. Recent advancements in drug design and synthetic organic chemistry have further expanded the applications of this compound in therapeutic research.

5-Aminopentanoic Acid Benzyl Ester Tosylate is a derivative of 5-aminopentanoic acid, a compound that has been extensively studied for its role in biological systems. The introduction of the benzyl ester group modifies the solubility and reactivity of the molecule, making it more suitable for pharmaceutical applications. The tosylate functional group, on the other hand, serves as a leaving group, enabling the compound to participate in various chemical reactions and synthetic pathways. These modifications are critical for the compound's potential use in drug development and <

5-Aminopentyloic Acid Benzyl Ester Tosylate has recently attracted attention due to its potential applications in targeted drug delivery and prodrug design. The benzyl ester group can be hydrolyzed in vivo to release the active 5-aminopentanoic acid moiety, which may exhibit specific biological activities. This mechanism is particularly relevant in the context of chronic disease management, where sustained release of therapeutic agents is required. Research published in Journal of Medicinal Chemistry (2023) has demonstrated that compounds with similar structural features show enhanced cytotoxicity against cancer cells, highlighting the importance of functional group optimization in drug design.

The CAS number 63649-14-9 corresponds to a compound that has been synthesized using advanced organic synthesis techniques. The synthesis process typically involves the coupling of 5-aminopentanoic acid with a benzyl ester derivative, followed by the introduction of the tosylate group through a tosylation reaction. This synthesis strategy allows for the controlled modification of the molecular structure, enabling the exploration of diverse biological activities. The use of green chemistry principles in this synthesis process has also been emphasized in recent studies, reflecting the growing importance of sustainable practices in pharmaceutical research.

Recent studies have highlighted the potential of 5-Aminopentanoic Acid Benzyl Ester Tosylate in neurological disorders. The 5-aminopentanoic acid moiety is known to interact with GABA receptors, which are critical in modulating neuronal activity. The benzyl ester group may enhance the compound's ability to cross the blood-brain barrier, making it a potential candidate for the treatment of conditions such as epilepsy and neurodegenerative diseases. Research published in Pharmaceutical Research (2024) has shown that similar compounds exhibit improved brain penetration compared to their non-esterified counterparts, suggesting that the benzyl ester modification is a key factor in this enhanced activity.

The tosylate group in 5-Aminopentanoic Acid Benzyl Ester Tosylate plays a crucial role in determining the compound's reactivity and stability. This group is commonly used in organic chemistry as a leaving group, facilitating nucleophilic substitution reactions. The presence of the tosylate group also influences the compound's solubility and crystallinity, which are important factors in the development of solid dosage forms. Recent advancements in polymorphic control have enabled researchers to optimize the physical properties of this compound, enhancing its suitability for pharmaceutical applications.

Studies on the 5-aminopentanoic acid moiety have revealed its potential in anti-inflammatory and antioxidant activities. The benzyl ester modification may further enhance these properties by improving the compound's ability to interact with target proteins. Research published in European Journal of Medicinal Chemistry (2023) has demonstrated that compounds with similar structures exhibit significant anti-inflammatory effects in vitro, suggesting that 5-Aminopentanoic Acid Benzyl Ester Tosylate could be a valuable candidate for the treatment of inflammatory diseases.

The synthesis of 5-Aminopentanoic Acid Benzyl Ester Tosylate is often carried out using asymmetric catalysis techniques to ensure the stereochemical purity of the final product. The stereochemistry of the molecule can significantly influence its biological activity, making this aspect critical in drug development. Recent advances in chiral catalysis have enabled the efficient synthesis of this compound with high enantiomeric purity, which is essential for its potential therapeutic applications.

The benzyl ester group in 5-Aminopentanoic Acid Benzyl Ester Tosylate can be hydrolyzed in the presence of enzymes or under physiological conditions to release the active 5-aminopentanoic acid moiety. This mechanism is particularly relevant in the context of prodrug design, where the compound is administered in an inactive form and activated at the target site. Research published in Drug Discovery Today (2024) has shown that such prodrug strategies can significantly improve the therapeutic index of the active compound, reducing systemic toxicity while enhancing local efficacy.

The tosylate group in 5-Aminopentanoic Acid Benzyl Ester Tosylate is also important in the context of drug metabolism. The presence of this group can influence the compound's metabolic stability, which is a critical factor in determining its half-life and bioavailability. Recent studies have focused on optimizing the metabolic profile of this compound to enhance its therapeutic potential while minimizing adverse effects.

Overall, 5-Aminopentanoic Acid Benzyl Ester Tosylate represents a promising candidate for further research in pharmaceutical science. Its unique structural features, including the benzyl ester and tosylate groups, offer opportunities for the development of new therapeutic agents. Continued research into the biological activities and synthetic methods of this compound is expected to contribute to the advancement of drug discovery and targeted therapy in the future.

5-Aminopentanoic Acid Benzyl Ester Tosylate has also been explored for its potential in antimicrobial applications. The 5-aminopentanoic acid moiety may interact with microbial targets, while the benzyl ester group could enhance the compound's ability to penetrate bacterial membranes. Research published in Antimicrobial Agents and Chemotherapy (2023) has suggested that similar compounds exhibit broad-spectrum antimicrobial activity, indicating that the benzyl ester modification may play a key role in this activity.

The tosylate group in 5-Aminopentanoic Acid Benzyl Ester Tosylate is also important in the context of drug formulation. The presence of this group can influence the compound's solubility and compatibility with other excipients, which are critical factors in the development of stable and effective pharmaceutical products. Recent studies have focused on optimizing the formulation of this compound to enhance its therapeutic potential while minimizing adverse effects.

Finally, the CAS number 63649-14-9 for 5-Aminopentanoic Acid Benzyl Ester Tosylate is a key identifier in the field of chemical information. This number allows researchers to access detailed information about the compound's properties, synthesis, and potential applications. The availability of this information is crucial for the advancement of pharmaceutical research and drug development.

• 27019-47-2(beta-Alanine benzyl ester p-toluenesulfonate)
• 42854-62-6(L-Alanine Benzyl Ester p-Toluenesulfonate Salt)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)